NSAIDs Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

benefit of NSAIDs

A

inhibiting down stream products of arachidonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

prostanoids

A

prostaglandins, prostacyclin and thromboxanes
produced locally on demand
short half lives- fine local control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

prostaglandin = PGE2 function

A

protective
regulation of acid secretion in parietal cells
GI mucosal protection
Uterine contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

prostacyclin, PGI2 function

A

inhibits platelet aggregation, ↑[cAMP] → ↓calcium vasodilator
protective, maintenance of blood flow and mucosal repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TXA2 function

A

platelet aggregation, ↑calcium and ↓cAMP in platelets vasoconstriction
bad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

COX1 function

A
GI protection (acid and mucus) 
Platelet aggregation 
Vascular resistance
Chronic inflammation Chronic pain 
Raised blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

COX2 function

A
Renal homeostasis 
Tissue repair and healing 
Reproduction (uterine contractions)
Inhibition of platelet aggregation
Chronic inflammation  Chronic pain 
Fever 
Blood vessel permeability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NSAIDs basic function

A

inhibition of COX
↓prostaglandin, prostacyclin and thromboxane synthesis
Compete with arachidonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NSAIDs - analgesia

A

• Local peripheral action at site of pain – greater efficacy if inflamed
• Inhibition of COX reduces peripheral pain fibre sensitivity by blocking PGE2
↓PGE2 synthesis in dorsal horn -
↓neurotransmitter release → ↓excitability of neurons in pain relay pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NSAIDs - anti-inflammatory

A

reduce production of prostaglandins released at site of injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NSAIDs - antipyretic

A

Inhibition of hypothalamic COX-2 (where cytokine induced prostaglandin synthesis is elevated)
results in a reduction in temperature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

COX selectivity

A

COX1 selective: aspirin
COX2 selective:celecoxib, etoricoxib
in between ibuprofen, naproxen,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
GI consideration
#,X,^
A

Dyspepsia, nausea, peptic ulceration, bleeding and perforation, exacerbation of IBD, reduced blood flow

↓mucus and bicarbonate secretion, ↑acid secretion • ↓mucosal blood flow → enhanced cytotoxicity and hypoxia

Xelderly, prolonged use, smoking, alcohol, history of peptic ulceration, helicobacter pylori

Δ aspirin, glucocorticoid steroids, anticoagulants (PPI should be considered)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Renal considerations

A

• # reversible ↓GFR ↓renal blood flow
↑Na, ↑H2O, ↑BP
X More likely in underlying CKD, heart failure
Δ ACEi, ARBs, diuretics
might constrict afferent arterial in kidney,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Selective COX2 inh

A
avoid inhibition of homeostatic
etoricoxib
actions mediated by COX-1 
less GI adverse effects
unopposed platelet aggravation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

protein binding

A

Displace other bound drugs → increasing free drug concentration
sulfonylurea – hypoglycaemia
methotrexate - accumulation and hepatotoxicity
warfarin – increased risk of bleeding

17
Q

indication for NSAIDs

A
  • Inflammatory conditions – joint and soft tissue
  • Osteoarthritis – topical NSAID and paracetamol should be tried first
  • Postoperative pain • Topical use on cornea
  • Menorrhagia (moderate reduction in blood loss)
  • Low dose aspirin for platelet aggregation inhibition
  • Opioid sparing when used in combination
18
Q

X NSAIDs

A
  • Cardiovascular disease – risk
  • Renal function - age
  • GI disease - previous use of NSAIDs
  • DDIs – ACEi and ARBs, steroids, diuretics, methotrexate, warfarin (not exhaustive list)
  • Level of pain, pyrexia, level of inflammation
  • Third trimester of pregnancy – not sustained use – delayed labour and early closure of ductus arteriosus
19
Q

NSAIDs use

A

Lowest effective dose for the shortest time necessary taking into account patient specific risk factors

20
Q

paracetamol

indication and mechanism

A

non-NSAID, non-opiate analgesic with antipyretic action
for analgesia AND fever
COX-2 selective inhibition in CNS (spinal chord) - ↓pain signals to higher centres
inactivated by conjugation in the liver

21
Q

NAPQI

A

Highly reactive metabolite
normal therapeutic doses - conjugation with glutathione renders NAPQI harmless
Hepatic glutathione is limited
highly nucleophilic-causing cell death – necrosis and apoptosis

22
Q

paracetamol overdose

A

asymptomatic for many hours
• Nausea, vomiting, abdominal pain – first 24h
• Maximal liver damage occurs at ~ 3-4 days
– i .v. acetylcysteine reduces toxic metabolites, by replacing glutathione